MAGGIE GORSKI: Open Payments
NPI 1144690819 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$423 in 21 payments from 12 companies in 2025. Trend: 2023 $541 · 2024 $1,042 · 2025 $423
Food & beverage: $423
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $83 |
| E.R. Squibb & Sons, L.L.C. | 3 | $73 |
| ABBVIE INC. | 2 | $54 |
| Supernus Pharmaceuticals, Inc. | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $41 |
| Noven Therapeutics, LLC | 2 | $31 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Alkermes, Inc. | 1 | $21 |
| Lundbeck LLC | 1 | $18 |
| Collegium Pharmaceutical, Inc. | 1 | $14 |
Products named: REXULTI, COBENFY, VRAYLAR, Qelbree, TRINTELLIX, Xelstrym, Auvelity, ARISTADA.
Industry payments across TX — which companies pay providers there.
